Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Is Taking On The Fight Against Cancer With Digital Pathology And AWS

By Author Proscia | June 19, 2019

While almost all of medicine has taken an enormous shift towards digitization, the diagnosis of diseases like cancer remains largely dependent on the human eye. Pathologists have relied on the microscope for the past 150 years, drawing on their training to perform complex pattern recognition. Proscia’s Concentriq software allows thousands of researchers and pathologists to host, organize, analyze, and share millions of tissue biopsy images, accelerating discoveries and driving the highest quality. However, two key challenges that are slowing the digitization process is how much data a whole slide image will occupy, and where that data should be stored. Continue reading to learn how Proscia partnered with AWS to address their data challenge and deliver Concentriq to pathologists around the world.

Our website uses cookies. By using this site, you agree to its use of cookies.